Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 437 of 6351
-
New hope for KRAS G12D lung cancer: targeted drug combo enters trial
Disease control Not yet recruitingThis study is a multicenter, open-label, randomized clinical trial aimed at exploring the efficacy and safety of three treatment regimens for treatment-naive advanced NSCLC patients with KRAS G12D mutation: GFH375 monotherapy (Cohort 1), GFH375 combined with cetuximab (Cohort 2),…
Phase 2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug combo aims to shrink tumors in advanced colorectal cancer
Disease control Not yet recruitingPhase II - Treatment Regimen Exploration Stage: 1. Evaluate the safety and efficacy of the following three treatment regimens: Liposomal irinotecan + 5-FU/LV + bevacizumab + Enlonstobart (Group A) Liposomal irinotecan + 5-FU/LV + bevacizumab (Group B) Irinotecan + 5-FU/LV + …
Phase 2/3 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a new drug slow lewy body dementia? phase 2 trial begins
Disease control Recruiting nowThe main purpose of this study is to evaluate whether treatment with donanemab slows the progression of cognitive (how we think, learn, remember, pay attention, and make decisions) and functional (how we are able to perform daily activities) decline. For each participant, the stu…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a genetically modified oral vaccine beat cholera?
Vaccine Recruiting nowCholera is a serious diarrheal disease that can be fatal within hours of onset. The current available cholera vaccines to prevent the disease are not very effective. Panchol is a new oral cholera vaccine that may be an improvement over the currently available vaccines in use. The…
Phase 1 • Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Vaccine
Last updated Jul 31, 2026 00:00 UTC
-
Can a lighter radiation punch still knock out rectal cancer?
Disease control Recruiting nowThis prospective, randomized phase II trial is designed to evaluate whether low-dose short-course radiotherapy differs from common-dose short-course radiotherapy in terms of efficacy when both regimens are sequentially combined with CAPOX, a PD-1 monoclonal antibody, and interleu…
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for liver cancer: experimental drug HH-009 enters human trials
Disease control Recruiting nowThis is a randomized, open-label, multicenter Phase Ib/II registration trial designed to evaluate the efficacy and safety of HH-009 in patients with FGF19-positive hepatocellular carcinoma (HCC). The study will also assess pharmacokinetics, pharmacodynamics, immunogenicity, and e…
Phase 1/2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common antibiotic help stroke patients walk again?
Disease control Recruiting nowAcute ischemic stroke (AIS) is a leading cause of mortality and long-term disability worldwide. Among these, stroke caused by large vessel occlusion (LVO) are associated with particularly poor outcomes. Multiple randomized controlled trials have demonstrated that endovascular thr…
Phase 2/3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to halt artery plaque after heart attacks
Disease control Recruiting nowThe CAPRA-EVO trial is a single-center, randomized, open-label study with blinded endpoint assessment comparing early evolocumab plus standard lipid-lowering therapy versus standard-of-care lipid-lowering therapy in patients with acute coronary syndrome after successful percutane…
Phase 4 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Personalized dosing could tame kidney cancer Drug's side effects
Disease control Recruiting nowAdverse events (AEs) with Cabozantinib are frequent (about 40-67% of patients) and often lead to temporary treatment interruptions, dose reductions or permanent discontinuations, potentially reducing dose intensity and sustained exposure. Therefore, strategies are needed to impro…
Sponsor: Centro di Riferimento Oncologico - Aviano • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Magic mushroom therapy aims to ease cancer Patients' fear and sadness
Symptom relief OngoingThis phase II trial tests the safety, side effects and how well group retreat psilocybin therapy works for the treatment of anxiety and depression in patients with solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic) …
Phase 2 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Stent after clot removal: a new hope for stroke patients?
Disease control Recruiting nowThe study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retriev…
Phase 3 • Sponsor: ProMedica Health System • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for rare GIST: targeted pill shows promise in early trial
Disease control Recruiting nowThe purpose of this study is to determine how effective the drug pemigatinib is as a treatment option for advanced succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors(GIST). This study will also assess the side effects associated with pemigatinib and evaluate …
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for Hard-to-Treat colorectal cancer? denikitug trial launches
Disease control Recruiting nowThe goal of this clinical study is to learn more about the study drug, Denikitug (DEN, GS-1811), to evaluate the efficacy and safety of Denikitug Monotherapy and Denikitug-based Combinations in participants with advanced microsatellite stable (MSS) colorectal cancer (CRC). The p…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Which ablation method best tames persistent AF? a Head-to-Head trial aims to find out
Disease control Recruiting nowThis study is aimed to compare the clinical efficacy of two different catheter ablation strategies in patients with persistent atrial fibrillation. Participants will be randomized 1:1 into either the Anatomy-based group or the Emphasize map-guided group * Anatomy-based group : …
Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Smartwatch therapy aims to unlock words stuck in the brain
Symptom relief Recruiting nowAnomia (i.e., impaired word retrieval) is one of the most common and debilitating deficits experienced by stroke survivors with aphasia, an acquired disorder characterized by impaired language. Although many anomia treatments exist, treatment response is modest and inconsistent a…
Sponsor: Northeastern University • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Could a weekly injection free people with type 1 diabetes from carb counting?
Disease control Recruiting nowThis research study is testing whether a weekly medication called tirzepatide can help adults with type 1 diabetes use their insulin pump more easily, specifically by reducing or eliminating the need to count carbohydrates at meals. People with type 1 diabetes must take insulin …
Phase 2/3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Inhaled powder could offer rapid migraine relief without needles
Symptom relief Recruiting nowThis study is testing an investigational inhaled migraine medication to see how well it works, how safe it is, and how well people tolerate it. Adults with migraine will receive both the study medication (ASY202) and a placebo (inactive treatment) at different times during the st…
Phase 2 • Sponsor: Aspeya, Inc. • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Magic mushrooms take on OCD: new trial tests doses for relief
Symptom relief Recruiting nowThe study tries to improve our treatments for people who have obsessive-compulsive disorder (OCD) by testing psilocybin, a mind altering drug that changes activity in brain areas involved in OCD. 30 patients with moderate or more severe OCD who are not taking mind altering medica…
Phase 1 • Sponsor: Francisco A Moreno • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New radioactive 'Smart Bomb' targets Hard-to-Treat lung cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of \[212Pb\]Pb-MP0712, in patients aged ≥18 years with Small Cell Lung Cancer and other locally advanced or metastatic DLL3 positive tumors.
Phase 1/2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a teacher workshop end school violence? a zambian trial aims to find out
Prevention Recruiting nowThe United Nations Conventions on the Rights of the Child UN General Assembly, 1989), outlawed violence against children worldwide. Yet, 75% of all children worldwide - experience violence while growing up (Know Violence in Childhood, 2017). In Low- and Middle-Income countries pr…
Sponsor: Tobias Hecker, PhD • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC